Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M.
Massano D, et al. Among authors: cesaro s.
Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2.
Pediatr Blood Cancer. 2022.
PMID: 35656841